LIN trades against a final fair-value range of $208.99-$355.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $209, high $356, with mid-point at $277.
Affichage de la source anglaise pendant la traduction
Ce rapport n'a pas encore été traduit. Actualisez dans quelques minutes une fois que la file d'attente de traduction aura rattrapé son retard.
§1 Résumé
Composite fair value $277 with high case $356.
Implied downside of 43.9% to fair value.
Moat 9/10 · confidence 87/100 · Cyclical.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$277
Margin of safety
-78.2%
Confidence
87/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$493.16Price
Low $208.99
Mid $276.69
High $355.92
LIN trades against a final fair-value range of $208.99-$355.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Cycle upside
Secular energy transition optimism and continuous pricing power drive unconstrained multiple expansion.
Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
FV impact
-40% downside to current share price
Trigger
12-24 months
Deep Industrial Recession
· Medium
Prolonged global manufacturing and metals recession drives base volumes down, completely offsetting the downside protection of take-or-pay minimums.
FV impact
Drives valuation to $208.99 bear case
Trigger
18 months
Green Capex Value Trap
· Medium
Accelerated clean energy investments require structurally higher capex without commensurate return on invested capital, impairing FCFF generation.
FV impact
-15% structurally to base case valuation
Trigger
24-36 months
Signaux d'alerte précoce à surveiller
Métrique
Actuel
Seuil de déclenchement
Capex to D&A ratio sustains aggressively above 1.5x without top-line revenue acceleration.
Monitor
Deterioration versus the report thesis
Measurable deterioration in renewal rates or pricing power for long-term take-or-pay contracts.
Monitor
Deterioration versus the report thesis
Global manufacturing PMI readings remaining decisively below 45 for three consecutive quarters.
Monitor
Deterioration versus the report thesis
Gross margin compression below 40%, signaling a loss of highly prized localized pricing power.
Monitor
Deterioration versus the report thesis
Significant downward revisions or delays in clean energy and hydrogen project backlogs.
Our financial-history view of LIN (LIN) covers revenue, gross profit, operating income, and net income across the past five fiscal years, with year-over-year growth and margin context for each line.
The revenue trajectory is reported in the financial-history section with year-over-year growth rates. Direction and acceleration are summarised inline; the full table sits within the parent financials tab.
We track operating income alongside operating margin so the reader can separate top-line growth from operating leverage. The numbers analysis subsection flags one-offs, restructuring, and stock-based-compensation effects when material.
Net income is shown together with EPS so dilution and buybacks are visible alongside profit. Where reported net income diverges materially from operating cash flow, the discrepancy is called out in the numbers-analysis subsection.
FAQ
LIN — frequently asked questions
Based on our latest analysis, LIN looks meaningfully overvalued. The current price is $493 versus a composite fair-value midpoint of $277 (range $209–$356), which implies roughly 43.9% downside to the midpoint.
Our composite fair-value range for LIN is $209–$356, with a midpoint of $277. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for LIN's archetype.
Our current rating for LIN is Sell with a confidence score of 87/100. LIN is rated Sell at $493.16 versus the reconciled fair value midpoint of $276.69, implying -43.89% upside/downside. Confidence is separately disclosed at 87/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for LIN are: Cyclical Multiple Reversion; Deep Industrial Recession; Green Capex Value Trap. The single biggest risk is Cyclical Multiple Reversion: Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
Our current rating for LIN is Sell, issued with a confidence score of 87/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($209–$356) versus the current price of $493.
LIN is classified as a cyclical stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for LIN.